KT2-962
KT2-962 is a thromboxane A2 (TXA2) receptor antagonist and potent hydroxyl radical scavenger (IC50=500 nM) . KT2-962 reduces myocardial infarct size and ventricular fibrillation. KT2-962 demonstrates cardioprotective effect in a canine ischemia/reperfusion model. KT2-962 is promising for research of myocardial ischemia-reperfusion injury and TXA2-mediated vascular diseases[1].
Product Specifications
CAS Number
[129648-96-0]
UNSPSC
12352005
Target
Prostaglandin Receptor
Related Pathways
GPCR/G Protein
Field of Research
Cardiovascular Disease
Smiles
O=S(C1=C2C=CC(C(C)C)=CC=C2C(CCCCNS(=O)(C3=CC=C(C=C3)Cl)=O)=C1)(O[Na])=O
Molecular Formula
C23H25ClNNaO5S2
Molecular Weight
518.02
References & Citations
[1]Ge ZD, et al. Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists. J Cardiovasc Pharmacol. 2003 Mar;41 (3) :481-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
TXA2/TP
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MM-419447-d4 Trifluoroacetic Acid Salt (Linaclotide Metabolite)
Recombinant Helicobacter pylori Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Recombinant Helicobacter pylori Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Recombinant Helicobacter pylori Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)